BNTC — Benitec Biopharma Ltd ADR

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Benitec Biopharma Ltd ADR

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$11.49
Market Cap$386M
Float17.8M
Shares Outstanding34.3M
Price/Sales (TTM)2,770.13
vs. Analyst Target+111.8% to analyst PT
Revenue (TTM)$7,000
Dividend RateNone
Analyst Target Price$24.33 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $97,000 -$8.3M $282,000 -$7.9M
2021 $59,000 -$13.9M -$64,000 -$13.5M
2022 $73,000 -$18.2M $64,000 -$17.9M
2023 $75,000 -$19.6M -$306,000 -$19.1M
2024 $216,000 -$21.8M -$343,000 -$21.4M
2025 N/A -$37.9M -$396,000 -$41.7M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Mar 2025 N/A -$9.4M
Jun 2025 $556,000 -$16.1M
Sep 2025 N/A -$9.0M
Dec 2025 N/A -$11.8M

Ownership & Float

Insider Ownership2.7%
Institutional Ownership96.7%
Short Float13.0%
% of All Funds Holding0.87%
Number of Funds Holding67

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$11.75Near-term / short-term trend
Weekly40-Week SMA$12.69Medium-term trend
Weekly80-Week SMA$12.59Cyclical trend (business cycle)
Weekly200-Week SMA$8.40Secular trend (multi-year)
Monthly10-Month SMA$12.73Near-term monthly trend
Monthly20-Month SMA$12.47Medium-term monthly trend
Monthly40-Month SMA$8.79Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$10.10 support 1.62x 16 months ago
$9.20 support 1.04x 18 months ago
$5.20 support 1.01x 24 months ago

Historical Earnings Reactions (37 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.36% -0.34% 45.95% 8.51% -65.14%
1 Day -1.55% 0.04% 51.35% 15.98% -55.14%
1 Week -1.25% -3.59% 43.24% 29.53% -52.29%
2 Weeks -2.79% -6.15% 35.14% 57.89% -50.70%
1 Month -3.52% -4.22% 43.24% 78.95% -50.70%

Next earnings: May 13, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan1.2%33.3%12
Feb8.8%58.3%12
Mar3.7%66.7%12
Apr3.6%50.0%12
May-4.6%45.5%11
Jun-13.2%18.2%11
Jul6.0%50.0%12
Aug-4.2%33.3%12
Sep-10.4%25.0%12
Oct-5.9%58.3%12
Nov-4.8%33.3%12
Dec-0.8%58.3%12

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.06% 41.6% 560
Tuesday 0.40% 44.4% 615
Wednesday -0.18% 42.4% 613
Thursday 0.38% 44.8% 600
Friday -0.34% 40.2% 599

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 96.7%

Insider Transactions — Smart Summary

Total insider ownership: 2.7%

12-Month Insider Activity Summary

Total Filings3
Net Value+N/A
Net Shares Change1,671,845
% of Float9.4%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
SUVRETTA CAPITAL MANAGEMENT, LLC +$22.4M 3 3 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-29 SUVRETTA CAPITAL MANAGEMENT, LLC +$1.9M Transaction at $13.20, now -12.9%
2025-12-22 SUVRETTA CAPITAL MANAGEMENT, LLC +$538,973.021 Transaction at $11.68, now -1.6%
2025-11-10 SUVRETTA CAPITAL MANAGEMENT, LLC +$20.0M Transaction at $13.50, now -14.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Benitec Biopharma Ltd ADR (BNTC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BNTC on Trend Edge →